Xenetic Biosciences

XBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.263 M

$3.17 +11.23%

Close of 7 Aug 2026

Revenue

$2.98M

#3387 by revenue

Earnings

-$2.68M

Loss-making

Shares outstanding

2,343,181

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#450Can-Fite BioPharmaCANF$7.37M
#451Addex TherapeuticsADXN$7.34M
#452Xenetic BiosciencesXBIO$7.26M
#453Xtl BiopharmaceuticalsXTLB$7.22M
#454Cadrenal TherapeuticsCVKD$6.96M

Where these numbers come from

Share counts and financials for Xenetic Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.